https://www.nature.com/articles/d41586-021-02054-z
Many vaccines have been shown to provide strong protection against COVID-19. Now, growing evidence finds that they also substantially reduce the risk of passing on the virus SARS-CoV-2 — crucial information for governments making decisions about how best to control the pandemic.
However, the studies were done before the highly transmissible Delta variant became prevalent — and scientists say it might be more easily spread by vaccinated people than are earlier variants.
Two studies
1,
2 from Israel, posted as preprints on 16 July, find that two doses of the vaccine made by pharmaceutical company Pfizer, based in New York City, and biotechnology company BioNTech, based in Mainz, Germany, are 81% effective at preventing SARS-CoV-2 infections. And vaccinated people who do get infected are up to 78% less likely to spread the virus to household members than are unvaccinated people. Overall, this adds up to very high protection against transmission, say researchers.
The studies reflect population-level trends, say researchers. “It’s good news,” says Natalie Dean, a biostatistician at Emory University in Atlanta, Georgia. “But it’s not quite good enough,” she notes, because it means that vaccinated people can still occasionally spread the infection.
And the highly transmissible
Delta variant is a major source of uncertainty. The Israeli studies and others are based on the circulation of earlier variants, in particular Alpha, but research suggests that vaccines offer slightly reduced protection against Delta.